Development and validation of a novel mRNA signature for predicting early relapse in non-small cell lung cancer

ConclusionsWe successfully established a reliable signature for predicting early relapse in stage I –III non-small cell lung cancer.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research